NCT07142954View on ClinicalTrials.gov

Epidemiology and Biomarker Study in Alzheimer's Disease

PHASE3RecruitingINTERVENTIONAL
Enrollment

3,400

Participants

Timeline

Start Date

August 25, 2025

Primary Completion Date

July 31, 2033

Study Completion Date

July 31, 2033

Conditions
Alzheimer Disease
Interventions
OTHER

P-tau217 Test

A plasma test measuring phosphorylated tau at Position 217 (P-tau217).

Trial Locations (3)

77054

RECRUITING

Care Access - Houston, Houston

113-8654

NOT_YET_RECRUITING

The University of Tokyo Hospital, Bunkyō City

130-0004

NOT_YET_RECRUITING

Souseikai Sumida Hospital, Tokyo

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY